Can Ibuprofen Delay Ovulation in Natural Cycle-IVF? (Ibudelay)
Investigation of Ibuprofen in the Delay of Ovulation in NC-IVF (Natural Cycle in Vitro Fertilisation) Therapy With the Objective of Reducing Premature Ovulation and Thus Improving Effectivity (Off Label Use)
Sponsor: IBSA Institut Biochimique SA
This PHASE2 trial investigates Fertilization in Vitro/Methods and Ovulation and is currently completed. IBSA Institut Biochimique SA leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Dec 2024 — Present [monthly]
Completed PHASE2
Status: Unknown → Completed
-
Sep 2024 — Dec 2024 [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jul 2023 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Jun 2022 — Jul 2023 [monthly]
Unknown Status PHASE2
▶ Show 7 earlier versions
-
Oct 2021 — Jun 2022 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE2
-
Jul 2019 — Jan 2021 [monthly]
Recruiting PHASE2
-
Nov 2018 — Jul 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jul 2017 [monthly]
Recruiting PHASE2
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- IBSA Institut Biochimique SA
- Insel Gruppe AG, University Hospital Bern
For direct contact, visit the study record on ClinicalTrials.gov .